Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Effects of Dry Needling in Athletes With Subacromial Pain Syndrome

3. juni 2026 opdateret af: Carlos Alberto Villarón Casales, Universidad Europea de Valencia

Effects of Dry Needling on Proprioception, Dynamic Stability, Strength, Pain Perception, and Disability in Athletes With Subacromial Pain Syndrome

The goal of this clinical trial is to evaluate whether dry needling combined with therapeutic exercise improves shoulder proprioception in amateur athletes with subacromial pain syndrome. The study will also assess its effects on dynamic stability, strength, pain, and functional disability.

The main questions this study aims to answer are:

Does dry needling improve shoulder proprioception compared with therapeutic exercise alone? Does dry needling improve dynamic shoulder stability and muscle strength? Does dry needling reduce pain and upper limb disability?

Researchers will compare a group receiving dry needling plus therapeutic exercise with a group performing therapeutic exercise alone to determine whether the combined intervention produces better outcomes.

Participants will:

Be randomly assigned to one of the two treatment groups. Perform a home-based therapeutic exercise program for 3 weeks. Complete assessments of proprioception, dynamic stability, strength, pain, and functional disability before and after the intervention.

Studieoversigt

Status

Ikke rekrutterer endnu

Detaljeret beskrivelse

Subacromial pain syndrome (SAPS) is one of the most common causes of shoulder pain and dysfunction in both the general population and athletes involved in repetitive upper-limb activities. In sports requiring overhead movements, throwing actions, or repetitive shoulder loading, the increased mechanical demand placed on the glenohumeral joint may contribute to functional impairments, persistent pain, and reduced athletic performance.

Several studies have reported proprioceptive deficits and sensorimotor control alterations in individuals with SAPS. These impairments may affect joint position sense, muscular coordination, and dynamic shoulder stability, potentially contributing to symptom persistence and increasing the risk of recurrent injury. Previous research has also associated proprioceptive deficits with higher pain intensity, functional disability, and reduced neuromuscular control.

Proprioception plays a fundamental role in sensory integration and in the regulation of precise and coordinated shoulder movements. Altered afferent input from muscular and articular structures may impair dynamic stabilization mechanisms and compromise upper-limb function during sports activities.

Dry needling is a minimally invasive physiotherapy technique widely used for the treatment of myofascial trigger points. Previous studies have demonstrated positive effects of dry needling on pain and functional disability in individuals with subacromial pain syndrome. In addition, research conducted in other joints has suggested that dry needling may influence motor control, postural stability, and proprioceptive mechanisms.

Despite the growing clinical interest in this intervention, there is currently limited evidence regarding the effects of dry needling on shoulder proprioception and sensorimotor variables in individuals with SAPS, particularly in athletic populations. Therefore, further investigation is needed to determine whether adding dry needling to a therapeutic exercise program may provide additional benefits for neuromuscular control and shoulder function.

The primary aim of this clinical trial is to evaluate the effectiveness of dry needling combined with therapeutic exercise on shoulder proprioception in amateur athletes with subacromial pain syndrome. Additionally, the study will assess the potential effects of the intervention on dynamic stability, shoulder isometric strength, pain perception, and upper-limb functional disability.

A randomized controlled trial with two parallel groups will be conducted. Participants will be randomly assigned in a 1:1 ratio to:

an experimental group receiving dry needling combined with therapeutic exercise, or a control group receiving therapeutic exercise alone.

The intervention period will last 3 weeks. Participants in the experimental group will receive two dry needling sessions separated by a 10-day interval. The technique will be administered by an experienced physiotherapist with specialized training in dry needling, following a predefined protocol based on the available scientific literature.

The intervention will target myofascial trigger points located in scapulohumeral muscles commonly associated with shoulder pain and subacromial pain syndrome. Trigger points will be identified through standardized clinical examination procedures.

Both groups will perform a structured home-based therapeutic exercise program focused on muscular strengthening, neuromuscular control, and shoulder function. Participants will receive individualized instructions, and adherence to the exercise program will be monitored using follow-up records.

Outcome assessments will be performed by an evaluator blinded to group allocation in order to minimize measurement bias. Measurements will be collected at three time points: baseline, 10 days after the first intervention session, and 10 days after the second intervention session, to evaluate changes in proprioception, dynamic stability, muscular strength, pain, and functional disability.

This study aims to provide clinical evidence regarding the potential role of dry needling as an adjunct to therapeutic exercise in the management of sensorimotor and functional impairments associated with subacromial pain syndrome in athletic populations. The findings may contribute to the development of more effective therapeutic strategies aimed at improving shoulder function and optimizing functional recovery in athletes with this condition.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

40

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

    • Valencia
      • Valencia, Valencia, Spanien, 46006
        • Clínica Dr Villarón
        • Kontakt:
        • Ledende efterforsker:
          • Carlos A Villarón Casales, PT, MSc, PhD
        • Underforsker:
          • Pablo Taberner Mortes, PT, MSc
        • Underforsker:
          • Alejandro Sendín Magdalena, PT, MSc, PhD
        • Underforsker:
          • Mathilde Conde Aparicio, PT, MSc
        • Underforsker:
          • Lucia Ortega Pérez de Villar, PT, MSc, PhD
        • Underforsker:
          • Javier Fenollar Cortes, PT, MSc, PhD
        • Kontakt:
          • Carlos A Villarón Casales, Clin. Dir.
          • Telefonnummer: + 34 611 68 62 26
          • E-mail: cvillaron@gmail.com

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • Men and women aged between 18 and 40 years.
  • Clinical diagnosis of subacromial pain syndrome (SAPS) according to the Dutch Orthopaedic Association criteria: presence of a painful arc and at least two positive tests among the following: Hawkins-Kennedy test, Neer sign, Jobe test, Drop Arm test, or Gerber test.
  • Participation in sports involving predominant upper-limb activity between 2 and 4 hours per week.

Exclusion Criteria:

  • Previous surgery involving the upper extremities.
  • Diagnosis of specific shoulder pathologies other than SAPS at the time of the study.
  • Receipt of medical or physiotherapy treatment within the month prior to the intervention.
  • Needle phobia or refusal to receive dry needling treatment.
  • Presence of vestibular disorders, balance impairments, or vascular alterations that could interfere with study measurements.
  • Confirmed or suspected pregnancy.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Dry needling + therapeutic exercise
Participants assigned to the experimental group will receive a combined intervention consisting of dry needling and a structured home-based therapeutic exercise program over a 3-week period. Dry needling will be applied to active myofascial trigger points in scapulohumeral muscles commonly associated with subacromial pain syndrome, including the supraspinatus, infraspinatus, subscapularis, teres minor, teres major, and anterior and middle deltoid muscles. Trigger points will be identified through standardized clinical examination based on the presence of a palpable taut band, a hypersensitive spot, reproduction of recognizable pain, and local twitch response. The intervention will be performed by a physiotherapist with more than 10 years of experience and certified training in dry needling, using a fast in-fast out technique with sterile disposable needles after skin disinfection with chlorhexidine.
Dry needling will be applied to active myofascial trigger points identified in scapulohumeral muscles commonly associated with subacromial pain syndrome, including supraspinatus, infraspinatus, subscapularis, teres minor, teres major, and anterior and middle deltoid muscles. Trigger points will be identified through standardized clinical examination. The intervention will be performed by an experienced physiotherapist using sterile disposable needles and a standardized fast in-fast out technique. Participants will receive two dry needling sessions separated by a 10-day interval.
Participants will perform a structured home-based therapeutic exercise program focused on shoulder strengthening, neuromuscular control, and sensorimotor function using elastic resistance bands. The exercise program will be performed three times per week for 3 weeks following a standardized protocol. Participants will receive individualized instruction, exercise materials, and adherence monitoring throughout the intervention period.
Aktiv komparator: Therapeutic exercise
Participants assigned to the control group will receive a structured home-based therapeutic exercise program over a 3-week period without dry needling intervention. The exercise program will focus on shoulder strengthening, neuromuscular control, and sensorimotor function using elastic resistance bands. Participants will perform the exercises three times per week for 3 weeks following a standardized protocol. All participants will receive individualized in-person instruction from a physiotherapist to ensure correct exercise execution. Participants will also receive the necessary exercise materials and an adherence diary to record compliance throughout the intervention period. The therapeutic exercise program will be identical to the experimental group in terms of exercise type, frequency, duration, supervision, and home-based format.
Participants will perform a structured home-based therapeutic exercise program focused on shoulder strengthening, neuromuscular control, and sensorimotor function using elastic resistance bands. The exercise program will be performed three times per week for 3 weeks following a standardized protocol. Participants will receive individualized instruction, exercise materials, and adherence monitoring throughout the intervention period.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Shoulder Proprioception Assessed With the Joint Position Sense Test
Tidsramme: Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Shoulder proprioception will be evaluated using the Joint Position Sense (JPS) test. Participants will actively reproduce a predefined shoulder position (abduction at 60°), and the absolute angular repositioning error in degrees will be recorded using an inclinometer. Scores range from 0 degrees (perfect repositioning) to no defined upper limit, with lower values indicating better proprioceptive accuracy.
Baseline, 10 days after the first intervention session, and 10 days after the second intervention session

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Pain Intensity Assessed With the Numeric Rating Scale
Tidsramme: Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Pain intensity will be assessed using the Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Lower scores indicate lower pain intensity.
Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Dynamic Shoulder Stability Assessed With the Upper Quarter Y Balance Test
Tidsramme: Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Dynamic shoulder stability will be assessed using the Upper Quarter Y Balance Test (YBT-UQ). Reach distances in the medial, inferolateral, and superolateral directions will be recorded in centimeters, with a minimum score of 0 cm and no predefined upper limit. Greater reach distance indicates better dynamic stability and sensorimotor performance.
Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Isometric Shoulder Strength Assessed With Handheld Dynamometry
Tidsramme: Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Isometric strength of the shoulder abductors and rotator muscles will be measured using a handheld dynamometer during maximal voluntary isometric contractions. Force values are recorded in Newtons, with a minimum of 0 N and no predefined upper limit. Higher force values indicate greater muscle strength.
Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Upper Limb Disability Assessed With the Disabilities of the Arm, Shoulder and Hand Questionnaire
Tidsramme: Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Functional disability of the upper limb will be assessed using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire, scored from 0 to 100, where 0 indicates no disability and 100 indicates maximum disability. Higher scores indicate greater disability and functional impairment.
Baseline, 10 days after the first intervention session, and 10 days after the second intervention session

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Carlos A Villaron Casales, PT, MSc, PhD, Universidad Europea de Valencia

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. juni 2026

Primær færdiggørelse (Anslået)

1. marts 2027

Studieafslutning (Anslået)

1. marts 2027

Datoer for studieregistrering

Først indsendt

27. maj 2026

Først indsendt, der opfyldte QC-kriterier

27. maj 2026

Først opslået (Faktiske)

2. juni 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

5. juni 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

3. juni 2026

Sidst verificeret

1. juni 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

Individual participant data will not be shared due to ethical and data protection constraints under Spanish and European regulations (RGPD, Ley Orgánica 3/2018). Anonymized aggregate results will be made available through publication in peer-reviewed journals

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner